BioTrinity Conference Focuses on NextGen Healthcare
Meeting Highlights Array of Technologies and Promising Methodologies
Supplement: CRISPR Enters the Clinic
Using CRISPR-Altered Cells to Fight Disease
Molecular Diagnostics Brings Patients Hope
NGS Advancements Pave the Way for New Drug-Resistance Research
Supplement: CRISPR in the Courthouse
An Interview with Law Professor Jacob Sherkow
For full access to this article login to GEN Select now.
CGH Sheds Its Light on Disease Etiology
Diseases that Have Defied Description Can Now Be Described and Explained
- Array comparative genomic hybridization (CGH) is illuminating DNA copy number variations (CNV) throughout the genome to diagnose disease etiology and to help tailor treatment regimens for patients to improve health outcomes. In January 2007, the College of American Pathologists and American Society of Clinical Oncology (CAP/ASCO) published guideline ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.